Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence
- PMID: 27838724
- PMCID: PMC5429025
- DOI: 10.1001/jama.2016.15212
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence
Conflict of interest statement
Comment in
-
Use of Statins in Adults Older Than 75 Years.JAMA. 2017 Mar 14;317(10):1081. doi: 10.1001/jama.2017.0382. JAMA. 2017. PMID: 28291887 No abstract available.
References
-
- Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1–S45. - PubMed
-
- Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER Study Group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–1630. - PubMed
-
- Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152(8):488–496. - PMC - PubMed
-
- Yusuf S, Bosch J, Dagenais G, et al. HOPE-3 Investigators. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2021–2031. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
